ArticleESMO gastrointestinal oncology2025
Concomitant proton pump inhibitors and capecitabine-based chemoradiotherapy in rectal cancer: an ancillary study from the PRODIGE 23 trial.
M Bridoux et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.